Phil Skolnick

26.6k total citations · 3 hit papers
430 papers, 21.9k citations indexed

About

Phil Skolnick is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Phil Skolnick has authored 430 papers receiving a total of 21.9k indexed citations (citations by other indexed papers that have themselves been cited), including 316 papers in Cellular and Molecular Neuroscience, 214 papers in Molecular Biology and 50 papers in Organic Chemistry. Recurrent topics in Phil Skolnick's work include Neuroscience and Neuropharmacology Research (274 papers), Receptor Mechanisms and Signaling (82 papers) and Neurotransmitter Receptor Influence on Behavior (77 papers). Phil Skolnick is often cited by papers focused on Neuroscience and Neuropharmacology Research (274 papers), Receptor Mechanisms and Signaling (82 papers) and Neurotransmitter Receptor Influence on Behavior (77 papers). Phil Skolnick collaborates with scholars based in United States, Poland and Belarus. Phil Skolnick's co-authors include Steven M. Paul, Ramón Trullás, Piotr Popik, Anthony S. Basile, Ian A. Paul, Rochelle D. Schwartz, Richard T. Layer, Peter D. Suzdak, Jacqueline N. Crawley and Moshe Rehavi and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Phil Skolnick

429 papers receiving 20.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.

1998 1.0k citations Phil Skolnick et al. profile →
Receptors for the Age of Anxiety: Pharmacology of the Benzodiazepines

1980 681 citations Phil Skolnick et al. profile →
International Union of Pharmacology. XV. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function

1998 515 citations Phil Skolnick et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phil Skolnick United States	77	14.4k	8.8k	3.0k	2.7k	2.0k	430	21.9k
Arvid Carlsson Sweden	86	18.0k 1.2×	10.5k 1.2×	2.9k 1.0×	2.6k 1.0×	1.6k 0.8×	444	29.6k
Edson X. Albuquerque United States	69	8.2k 0.6×	12.5k 1.4×	1.4k 0.5×	4.8k 1.8×	2.7k 1.4×	284	19.8k
Mark J. Millan France	70	10.4k 0.7×	7.0k 0.8×	2.7k 0.9×	2.7k 1.0×	1.6k 0.8×	284	19.3k
E. Costa United States	97	19.3k 1.3×	14.9k 1.7×	3.3k 1.1×	1.6k 0.6×	1.3k 0.7×	466	31.0k
Robert B. Innis United States	84	10.6k 0.7×	6.5k 0.7×	3.8k 1.3×	2.9k 1.1×	1.7k 0.9×	412	25.7k
Kenner C. Rice United States	73	17.2k 1.2×	11.2k 1.3×	2.0k 0.7×	4.9k 1.8×	1.7k 0.8×	792	29.1k
Trevor Sharp United Kingdom	68	11.4k 0.8×	5.5k 0.6×	3.0k 1.0×	1.9k 0.7×	1.1k 0.5×	264	16.2k
Francesc Artigas Spain	66	9.5k 0.7×	4.6k 0.5×	2.6k 0.9×	3.5k 1.3×	1.9k 0.9×	276	14.5k
Peter Riederer Germany	91	12.2k 0.8×	9.8k 1.1×	2.2k 0.7×	3.1k 1.1×	2.3k 1.2×	534	35.4k
Daniël Hoyer Switzerland	83	13.3k 0.9×	13.9k 1.6×	2.3k 0.8×	1.8k 0.7×	612 0.3×	371	26.6k

Countries citing papers authored by Phil Skolnick

Since Specialization

Citations

This map shows the geographic impact of Phil Skolnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Skolnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Skolnick more than expected).

Fields of papers citing papers by Phil Skolnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Skolnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Skolnick. The network helps show where Phil Skolnick may publish in the future.

Co-authorship network of co-authors of Phil Skolnick

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Skolnick. A scholar is included among the top collaborators of Phil Skolnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Skolnick. Phil Skolnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laffont, Céline M., et al.. (2025). Reversal of a synthetic opioid overdose: Insights from a validated translational model. Neuropharmacology. 278. 110546–110546.

Skolnick, Phil, et al.. (2024). Synthetic opioids have disrupted conventional wisdom for treating opioid overdose. SHILAP Revista de lepidopterología. 12. 100268–100268. 5 indexed citations

Webster, Lynn R., et al.. (2024). Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone. The Journal of Clinical Pharmacology. 64(7). 828–839. 9 indexed citations

Skolnick, Phil, et al.. (2019). Cannabinoid1 (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose. Journal of Neural Transmission. 127(2). 279–286. 5 indexed citations

Krieter, Philip A., et al.. (2019). Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose. Journal of Pharmacology and Experimental Therapeutics. 371(2). 409–415. 44 indexed citations

Bespalov, Anton, Thomas Steckler, & Phil Skolnick. (2019). Be positive about negatives–recommendations for the publication of negative (or null) results. European Neuropsychopharmacology. 29(12). 1312–1320. 27 indexed citations

Krieter, Philip A., et al.. (2019). Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects. Drug Metabolism and Disposition. 47(7). 690–698. 10 indexed citations

Volkow, Nora D., Janet Woodcock, Wilson M. Compton, et al.. (2018). Medication development in opioid addiction: Meaningful clinical end points. Science Translational Medicine. 10(434). 40 indexed citations

Warnock, Kaitlin T., et al.. (2012). Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology. Pharmacology Biochemistry and Behavior. 103(1). 111–118. 24 indexed citations

10.

Tran, P., et al.. (2011). Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Journal of Psychiatric Research. 46(1). 64–71. 71 indexed citations

11.

Skolnick, Phil, Piotr Popik, & Ramón Trullás. (2009). Glutamate-based antidepressants: 20 years on. Trends in Pharmacological Sciences. 30(11). 563–569. 317 indexed citations

12.

Skolnick, Phil, Piotr Popik, Aaron Janowsky, Bernard Beer, & Arnold Lippa. (2003). Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor. European Journal of Pharmacology. 461(2-3). 99–104. 117 indexed citations

13.

Hoo, Ken H., Geihan Rizkalla, Tine B. Stensbøl, et al.. (1999). [3H]ATPA: a high affinity ligand for GluR5 kainate receptors. Neuropharmacology. 38(12). 1811–1817. 25 indexed citations

14.

Skolnick, Phil. (1997). Antidepressants : new pharmacological strategies. Humana Press eBooks. 51 indexed citations

15.

Zhou, Liming, Anna‐Maria Costa, Kelvin A. Yamada, et al.. (1997). (2 S,4 R)-4-Methylglutamic Acid (SYM 2081): A Selective, High-Affinity Ligand for Kainate Receptors. Journal of Pharmacology and Experimental Therapeutics. 280(1). 422–427. 105 indexed citations

16.

Palfreyman, Michael G., Ian J. Reynolds, & Phil Skolnick. (1994). Direct and allosteric control of glutamate receptors. CRC Press eBooks. 42 indexed citations

17.

Wong, Garry, Konrad F. Koehler, Phil Skolnick, et al.. (1993). Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors. Journal of Medicinal Chemistry. 36(13). 1820–1830. 49 indexed citations

18.

Winslow, James, Thomas R. Insel, Ramón Trullás, & Phil Skolnick. (1990). Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor. European Journal of Pharmacology. 190(1-2). 11–21. 73 indexed citations

19.

Jones, E. Anthony, Anthony S. Basile, & Phil Skolnick. (1990). Hepatic Encephalopathy, GABA-ergic Neurotransmission and Benzodiazepine Receptor Ligands. Advances in experimental medicine and biology. 272. 121–134. 12 indexed citations

20.

Martin, Joseph V., Karen F. Berman, Phil Skolnick, & Wallace B. Mendelson. (1989). Behavioral and electroencephalographic effects of the adenosine1 agonist, L-PIA. Pharmacology Biochemistry and Behavior. 34(3). 507–510. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact